A. Ribas
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 12
- Cutaneous Melanoma Detection and Management 8
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Melanoma and MAPK Pathways 12
- Co-authors
- Igor Aurer (1 shared paper)Joaquim Bellmunt B (5 shared papers)Gale Rp (1 shared paper)Georgina Venetia Long (10 shared papers)Joan Albanell (3 shared papers)Igor J. Puzanov (5 shared papers)Frank Stephen Hodi (5 shared papers)Reinhard Dummer (9 shared papers)
- Journals
- Annals of Oncology (17 papers)European Journal of Cancer (6 papers)Cancer Chemotherapy and Pharmacology (1 paper)Melanoma Research (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
A. Ribas
34 papers receiving 331 citations
Peers
Comparison fields: 5 of 35
- Oncology 185
- Cancer Research 19
- Hematology 18
- Molecular Biology 61
- Surgery 31
Countries citing papers authored by A. Ribas
This map shows the geographic impact of A. Ribas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ribas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ribas more than expected).
Fields of papers citing papers by A. Ribas
This network shows the impact of papers produced by A. Ribas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ribas. The network helps show where A. Ribas may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Ribas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 53 | |
| 2 | 2022 | 46 | |
| 3 | Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis. | 1996 | 41 |
| 4 | 2002 | 29 | |
| 5 | What is the role of recombinant colony stimulating factors in bone marrow transplantation? | 1990 | 23 |
| 6 | 2014 | 23 | |
| 7 | 2017 | 15 | |
| 8 | Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with V600E BRAF-mutated melanoma | 2011 | 13 |
| 9 | 2015 | 13 | |
| 10 | Vemurafenib improves overall survival compared to dacarbazine in advanced BRAFV600E mutated melanoma: an update from the phase III randomized, open-label, multicenter BRIM3 trial | 2011 | 7 |
| 11 | 2015 | 7 | |
| 12 | 2017 | 7 | |
| 13 | 2018 | 7 | |
| 14 | 1997 | 6 | |
| 15 | 2014 | 6 | |
| 16 | 2018 | 5 | |
| 17 | 2012 | 4 | |
| 18 | 2014 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2025 | 4 |
About A. Ribas
A. Ribas is a scholar working on Oncology, Molecular Biology, Hematology, Cancer Research and Surgery, having authored 34 papers that have together received 341 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Melanoma and MAPK Pathways (12 papers), Cutaneous Melanoma Detection and Management (8 papers), Bladder and Urothelial Cancer Treatments (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Breast Cancer Treatment Studies (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Oncology (185 citations), Cancer Research (19 citations), Hematology (18 citations), Molecular Biology (61 citations) and Surgery (31 citations). A. Ribas has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Igor Aurer, Joaquim Bellmunt B, Gale Rp, Georgina Venetia Long, Joan Albanell, Igor J. Puzanov, Frank Stephen Hodi, Reinhard Dummer, John M. Kirkwood and Isabel Caragol. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Cancer Chemotherapy and Pharmacology, Melanoma Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.